ST. LOUIS, Ohio-A new study from Washington University in St. Louis shows cheaper antibiotics are as effective as newer, more expensive pharmaceuticals when treating uncomplicated sinusitis.
The research, to be published in The Journal of the American Medical Association, found that 17 different antibiotics were being prescribed to sinusitis patients. These drugs were classified as either first-line (amoxicillin, co-trimoxazole, and crythomycin) or second-line (clarithromycin and amoxicillin-clavulante). First-line drugs are typically cheaper and were found to help patients 90.1% of the time. In comparison, second-line drugs, which cost on average twice as much as first-line, were effective 90.8% of the time.
The researchers concluded the difference in efficacy was so slight that patients should be aware of the financial benefits of first-line pharmaceuticals.
"Our findings suggest that doctors should keep it simple when treating adults for acute, uncomplicated sinusitis," says Jay F. Piccirillo, MD, associate professor of otolaryngology and lead author of the study.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.